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INTRODUCTION
SOX  proteins  constitute  a  large  family  of  diverse 
and well-conserved transcription factors implicated 
in the control of various developmental processes 
(Pevny  and L o v e l l-B a d g e, 1997). SOX pro-
teins carry a DNA-binding HMG domain and dis-
play properties of both classical transcription factors 
and architectural components of chromatin (Pevny 
and L o v e l l - B a d g e, 1997). They perform their 
functions in a complex interplay with other tran-
scription factors in a manner highly dependent on 
cell type and promoter context (K a m a c h i et al., 
2000). 
Sox18/SOX18 is a member of the SOX gene fam-
ily which is transiently expressed in nascent endo-
thelial  cells  during  embryonic  development  and 
adult neovascularization, suggesting that Sox18 may 
constitute a major determining gene for endothelial 
cell specification or differentiation (D o w n e s and 
K o o p m a n, 2001). Furthermore, murine Sox18 
has been shown to be involved in the induction of 
angiogenesis during wound healing and tissue repair 
(D a r b y  et al., 2001). It has also been demonstrated 
that  interference  with  its  function  inhibits  blood 
vessel  formation  and  subsequent  tumor  growth 
(Young et al., 2006).
Human  SOX18  was  previously  shown  to  be 
expressed  in  a  variety  of  fetal  and  adult  tissues 
(Stanojcic and S t e v a n o v i c, 2000) and recent-
ly it was recently reported that SOX18 plays a role in 
atherosclerosis in humans (G a r c i a-Ramirez et 
al., 2005).
The  importance  of  SOX18  in  vascular  devel-
opment is revealed by the vascular defects caused 
by  Sox18/SOX18  mutations  in  mice  and  humans. 
Mutations  in  Sox18  underlie  the  mutant  pheno-
type of “ragged” mutant mouse (D o w n e s and 
Koopman, 2001), and mutations in human SOX18 
are associated with the hypotrichosis-lymphedema-
telangiectasia syndrome (I r r t h u m et al., 2003).
Mounting  evidence  indicate  that  the  Sox18/
SOX18 gene is an important regulator of vascular 
development, playing a role in endothelial cell speci-
fication or differentiation, atherogenesis, and angio-
genesis. Nevertheless, little is known about the tran-
scriptional regulation of human SOX18 gene itself, 
and isolation and characterization of its promoter 
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have not been reported. As the first step towards 
understanding molecular mechanism(s) underlying 
the regulation of human SOX18 expression, the aim 
of this study was to establish an adequate model sys-
tem for analysis of its transcriptional regulation and 
to clone and give the first characterization of the 5´ 
flanking region of this gene. 
MATERIALS AND METHODS
Cell culture
HeLa (ATCC CCL 2) and HepG2 (ATCC HB 
8065) cells were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% 
fetal bovine serum (FBS) and 1 x MEM nonessential 
amino acids at 37°C in 5% CO2. NT2/D1 (Andrews, 
1984) cells were maintained as described previously 
(K o v a c e v i c - G r u j i c i c et al., 2005). 
RT-PCR analysis
The reverse transcription reaction was achieved 
using 5 µg of total RNA with polyT reverse prim-
er by SuperScriptTM RnaseH- reverse transcriptase 
(Invitrogen). The PCR reaction was achieved with 
the following SOX18 specific primers: 
Forward primer F3: 5’GAGCCGGGGCGCTAT
GGCCTC3′ (+133)
Reverse primer R8: 5′AGGCCGTCCAGAGGC
GAGCGCTC3′ (+684) 
The  numbers  indicated  in  parentheses  corre-
spond to the distance in nt from the 5’ end of the 
sequence to the ATG that represents the translation 
start site. Products were analyzed using 1% agarose 
gel stained with ethidium bromide.
Northern blot analysis
Messenger RNAs from HeLa, HepG2, and NT2/
D1  cells  were  blotted  on  HybondTM  N+  mem-
brane  (Amersham  Pharmacia  Biotech).  The  DNA 
probe  was  generated  by  HindIII/PstI  digestion  of 
SOX18 cDNA clone ICRFp507M16113 (AJ243896) 
and  radiolabeled  with  [α32P]  dCTP  using  10  U 
of  the  Klenow  fragment  (Amersham  Pharmacia 
Biotech) according to the procedure of Mega Prime 
Labeling Systems (Amersham Pharmacia Biotech). 
Hybridization was performed overnight at 65°C in 
a buffer containing 0.5 M Na2HPO4 (pH 7.2), 7% 
SDS, and 1 mM EDTA, followed by three washes 
for 5 minutes at 65°C in washing buffer (40 mM 
Na2HPO4, 1% SDS). 
Western blotting 
HeLa cells were collected with 1x trypsin, washed 
twice in 1x PBS buffer and lyzed with lysis buffer 
containing 50M m Tris HCl (pH 8.0), 150 mM NaCl, 
1% NP40, 5 μg/ml PMSF, 1 μg/ml aprotinin, 1 μg/ml 
leupeptin, and 1 μg/ml pepstatin. Proteins were sep-
arated in by SDS-PAGE in 10% gel using a BioRad 
minigel  apparatus  and  then  electrotransfered  to  a 
nitrocellulose  membrane  (Amersham  Pharmacia 
Biotech). The membrane was blocked in 10% non-
fat milk for 1 h, then incubated by the incubation 
with primary SOX18 antibody (sc-20100) for 1 h at 
room temperature. Complexes were detected with 
horseradish peroxidase-linked secondary antibody 
and  an  ECL  detection  kit  (Amersham  Pharmacia 
Biotech). Actin antibody (sc-10731) was used as a 
positive control.
Cloning of the 5’ regulatory region of the SOX18 gene 
and generation of the CAT reporter construct
The 5´ flanking region of the SOX18 gene was 
subcloned  from  the  genomic  λ  clone  as  the  PstI-
PvuII fragment 892 bp in size that encompasses the 
region immediately upstream from the translation 
start point (ATG codone) (Fig. 2). This fragment 
was first cloned in the pBSKS+ vector and subse-
quently released by HindIII-BamHI and cloned in 
pBLCAT6 to generate clone 892pCAT6. 
In silico analysis of the SOX18 5′ upstream regulatory 
region
Analysis  of  GC  content  was  performed  using 
the  EMBOSS  CpGplot  program  (http://www.ebi.
ac.uk/emboss/cpgplot/)  and  promoter  prediction 
accomplished by PromoterInspector search (www.
genomatix.de/). 
Transient transfection assays
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phosphate  precipitation  method.  Cells  (1.2  x  106) 
were seeded in a 10 cm dish (two dishes per trans-
fection) and transfected with 20 µg of the SOX18 
promoter construct together with 6 µg of the pCH110 
vector (Amersham Pharmacia Biotech) and 8 µg of 
pBluescript (Stratagene) for 48 h. β-gal assays were 
performed  with  the  β-galactosidase  enzyme  assay 
system (Promega) and chloramphenicol acetyltrans-
ferase (CAT) activities were determined using the 
CAT  enzyme  linked  immunosorbent  assay  (CAT 
ELISA, Roche). The promoter-less vector pBLCAT6 
was used as a negative control and vector pBLCAT5 
was used as a positive control (containing the thy-
midine kinase-tk promoter). Statistical significance 
was determined by Student’s t-test, a difference of 
p<0.05 being considered significant.
RESULTS
Endogenous expression of the SOX18 gene in cultured cells
Considering that the human SOX18 gene has an 
essential role in early development, as well as in adult 
tissues, we set out to establish an adequate in vitro 
model system for studying its transcriptional regu-
lation. Accordingly, we have investigated the SOX18 
expression profiles in different cultured cell lines. In 
so doing we tested by RT-PCR three different per-
manent cell lines: the cervix adenocarcinoma-HeLa 
cell line, hepatocellular carcinoma-HepG2 cell line, 
and embryonal carcinoma- NT2/D1 cell line. Since 
the human SOX18 gene contains an intron within 
the HMG box region (196 bp in size), we used prim-
ers designed to encompass this region. These prim-
ers give amplification products of different size on 
genomic DNA (678 bp in size, Fig. 1A, lane 1) or on 
cDNA obtained by reverse transcription (482 bp in 
size, Fig. 1A, lanes 2, 3 and 4). By applying RT-PCR, 
we showed that SOX18 gene is expressed in all ana-
lyzed cell lines (Fig. 1A). Further, in order to quan-
tify SOX18 expression in those cell lines, we per-
formed Northern blot analysis. This analysis showed 
among the tested cell lines, HeLa cells expressed the 
highest level of SOX18, which is demonstrated by 
the presence of a transcript approximately 1800 nt 
in size (Fig. 1B). Length of the transcript is in agree-
ment with previously reported data (A z u m a et 
al., 2000). In contrast, no expression was detected in 
NT2/D1 and HepG2 cells, suggesting that the level   
Fig. 1. SOX18 expression analysis in cultured cell lines.
A: Expression analysis by RT-PCR. PCR on genomic DNA (lane 1); and PCR on cDNA from HepG2 (lane 2), HeLa (lane 3) and 
NT2/D1 (lane 4) cells. M -1Kb ladder.
B: Northern blot analysis. Two micrograms of mRNA from HepG2 (lane 1), HeLa (lane 2), and NT2/D1 (lane 3) cells were hybrid-
ized with a SOX18 specific probe. The SOX18 transcript is marked by an arrow. M- 0.24-9.5 Kb RNA ladder.
C: Western blot analysis. HeLa protein extracts (10, 25, and 50 μg, lanes 1, 2, and 3, respectively) were separated on SDS gel and the 
presence of SOX18 protein was detected by specific anti-SOX18 antibody. M - Protein molecular weight marker.I. PETROVIĆ and M. STEVANOVIĆ 270
of expression of the SOX18 gene in these cell lines 
is much lower and can not be detected by Northern 
blot analysis (Fig. 1B). 
Further,  in  order  to  demonstrate  expression 
of the SOX18 protein in HeLa cells, we performed 
Western  blot  analysis  using  specific  anti-SOX18 
antibody. Western blotting revealed the presence of 
the SOX18 protein, approximately 45 kD in size, in 
HeLa cells (Fig. 1C). Since we demonstrated expres-
sion of the SOX18 gene on both the RNA and the 
protein level in HeLa cells, in our subsequent studies 
we used this cell line as a model system for studying 
the mechanisms involved in transcriptional regula-
tion of SOX18 expression.
Cloning and in silico analysis of the 5´ flanking region 
of the human SOX18 gene
In order to understand the mechanisms involved 
in  regulation  of  SOX18  gene  expression,  we  first 
cloned and in silico analyzed the 5´ flanking region of 
this gene. The 5´ flanking region of the human SOX18 
gene was subcloned from the genomic λ clone as a 
PstI-PvuII fragment (892 bp) and further character-
ized by restriction mapping and sequencing (Fig. 2).
The  obtained  sequence  was  subjected  to 
PromoterInspector  search  (www.genomatix.de/), 
and  the  region  369  bp  upstream  from  ATG  was 
identified  as  a  potential  promoter  region  of  the 
SOX18 gene (Fig. 2). Further, the 892 bp sequence 
from  the  SOX18  5´  flanking  region  was  analyzed 
using the EMBOSS CpGplot program (http://www.
ebi.ac.uk/emboss/cpgplot/). One CpG island of 239 
bp in size was identified in the region positioned -
300 to -61 relative to ATG, which overlaps with the 
predicted promoter region (Fig. 2). 
Transcriptional activity of the SOX18 5’ flanking region 
In order to identify the region responsible for 
regulation  of  SOX18  expression,  we  analyzed  the 
ability of the cloned PstI-PvuII 5′ flanking fragment 
892 bp in size to drive expression of the cat reporter 
gene.  This  region  was  cloned  into  the  promoter-
less cat reporter vector pBLCAT6 and transfected 
in HeLa cells. The 892pCAT6 construct displayed 
high reporter activity compared to both the negative 
(pBLCAT6) and the positive (pBLCAT5) control in 
which expression of the cat reporter gene is driven 
by the herpes simplex virus thymidine kinase pro-
moter (HSV-TK) (Fig. 3). 
Our results indicate that the fragment 892 bp 
upstream  from  ATG  (clone  892pCAT6)  harbors 
regulatory elements sufficient for transcription and 
represents the SOX18 promoter region. 
Fig.  2.  Schematic  representation  of  the  SOX18  5´  flanking 
region and relative positions of restriction sites used for gen-
eration of the promoter construct.
The predicted promoter obtained by PromoterInspector 
search is indicated by a dashed line, while a CpG island pre-
dicted by EMBOSS CpGplot program is indicated by a dotted 
line. CAT- chloramphenicol acetyl transferase reporter gene. 
ATG-translation start site
Fig. 3. Promoter activity of the 892pCAT6 reporter gene con-
struct in HeLa cells. Normalized CAT activities were evaluated 
as a percentage of the pBLCAT5 control vector, which was set 
as 100%, and are presented as the means ± S. D. of at least 
three  independent  experiments.  Statistical  significance  was 
determined by Student’s t test, a difference of p<0.005 being 
considered significant.THE HUMAN SOX18 GENE: EXPRESSION ANALYSIS  271
DISCUSSION
In the past few years, crucial steps have been 
taken in understanding the biological function of 
the  SOX18  protein.  Mounting  evidence  indicates 
that the Sox18/SOX18 gene is an important regu-
lator  of  vascular  development,  playing  a  role  in 
endothelial cell specification or differentiation, ath-
erogenesis  and  angiogenesis  (D  o  w  n  e  s  and 
Koopman, 2001). Its function has recently been 
linked  with  some  pathophysiological  processes, 
including  atherosclerosis  and  tumor  angiogenesis 
(Garcia-Ramirez  et al., 2005; Y o u n g et al., 
2006). Although involvement of the Although involvement of the Sox18/SOX18 
gene in many vital processes during development 
and in adult life has been reported, little is known 
about the mechanism governing involved in regula-
tion of its expression. Much previous research was 
focused on SOX18 expression analyses in different 
tissues in vivo, but an in vitro model system that 
would permit the study of transcriptional regulation 
and functional characterization of its promoter has 
not been reported previously. Accordingly, we set 
out to establish an adequate in vitro model system 
for studying transcriptional regulation of the human 
SOX18  gene.  By  investigating  SOX18  expression 
profiles in different cultured cell lines, we showed 
that HeLa, HepG2, and NT2/D1 cell lines express 
this gene at a level that can be detected by RT-PCR 
(Fig.  1A).  However,  Northern  blot  analysis  (Fig. 
1B)  demonstrates  that  SOX18  expression  can  be 
detected  in  HeLa  cells  only,  suggesting  that  this 
cell  line  represents  an  appropriate  in  vitro  model 
system  for  studying  transcriptional  regulation  of 
the human SOX18 gene. Further, by Western blot 
analysis revealed the presence of the SOX18 protein 
in HeLa cells (Fig. 1C) indicating that this cell line 
contains all factors necessary for protein expression 
of the given gene.
In order to understand the mechanisms involved 
in regulation of SOX18 gene expression, our next 
goal was to clone and give the first characterization 
of the 5´ flanking region of the human SOX18 gene. 
To this end, we cloned the PstI-PvuII fragment 892 
bp  in  size  encompassing  the  region  immediately 
upstream from the translation start codone of the 
gene in question. This fragment from the SOX18 5´ 
flanking region was further characterized by restric-
tion mapping and sequencing. In silico analysis of the 
obtained sequence performed by PromoterInspector 
search revealed the presence of a potential promoter 
of the SOX18 gene within the PstI-PvuII fragment 
in the region positioned 369 bp upstream from the 
translation start codone (Fig. 2). We therefore tested 
the transcriptional activity of this fragment by clon-
ing  it  into  the  promoter-less  cat  reporter  vector 
pBLCAT6 and by transfecting it into HeLa cells. The 
construct displayed high reporter activity, indicat-
ing that the fragment 892 bp immediately upstream 
from ATG harbors regulatory elements sufficient for 
transcription  and  represents  the  SOX18  promoter 
region (Fig 3). 
The human SOX18 gene is an important factor 
in early stages of embryonic development, and there 
is strong evidence indicating that GC-rich cis ele-
ments play an essential role in the early embryonic 
development of mammals (M a r i n et al., 1997). 
The sequence of the SOX18 5´ flanking region was 
therefore analyzed in silico by applying the EMBOSS 
CpGplot program. When this program was applied, 
one CpG island 239 bp in size that overlaps with 
the predicted promoter region was identified in the 
region positioned -300 to -61 relative to ATG (Fig. 
2). Since the GC-rich cis-regulatory elements and 
their cognate binding proteins have been strongly 
implicated  in  developmental  gene  regulation,  fur-
ther work is needed in order to identify regulatory 
elements within the GC-rich region of the SOX18 
promoter  that  are  essential  for  its  transcriptional 
regulation. 
To conclude, in this paper we have presented the 
expression analysis, cloning, and first characteriza-
tion of the 5´ flanking region of the human SOX18 
gene. We have also shown that the region 892 bp in 
size  immediately  upstream  from  the  start  codone 
harbors regulatory elements sufficient for transcrip-
tion  and  represents  the  SOX18  promoter  region. 
Given the critical role of SOX18 during embryonic 
development  and  adult  neovascularization,  tran-
scriptional regulation of this human gene requires 
further analysis.
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ХУМАНИ SOX18 ГЕН: ЕКСПРЕСИОНА АНАЛИЗА И КАРАКТЕРИЗАЦИЈА УЗВОДНОГ 
РЕГУЛАТОРНОГ РЕГИОНА
ИСИДОРА ПЕТРОВИЋ и МИЛЕНА СТЕВАНОВИЋ
Институт за молекуларну генетику и генетичко инжењерство, 11010 Београд, Србија
Циљ  овог  рада  био  је  усﾭпосﾭтављање  одго-
варајућег in vitro модел сﾭисﾭтема за проучавање 
транﾭсﾭкрипционﾭе регулације ексﾭпресﾭије хуманﾭог 
SOX18 генﾭа. У овом раду приказанﾭа је ексﾭпресﾭи-
онﾭа анﾭализа SOX18 генﾭа у перманﾭенﾭтнﾭим ћелиј-
сﾭким линﾭијама као и прва карактеризација узвод-
нﾭог регулаторнﾭог регионﾭа овог генﾭа. Применﾭом 
RT-PCR,  Northern  i  Western  blot  есﾭеја,  усﾭтанﾭо-
вљенﾭо  је  да  је  SOX18  генﾭ  ексﾭпримиранﾭ  у  HeLa 
ћелијсﾭкој  линﾭији  и  да  ове  ћелије  предсﾭтављају 
адекватанﾭ  модел  сﾭисﾭтем  за  проучавање  транﾭ-
сﾭкрипционﾭе  регулације  ексﾭпресﾭије  овог  генﾭа. 
Такође, у овом раду је приказанﾭо и клонﾭирање 
и  прва  карактеризација  узводнﾭог  регулаторнﾭог 
регионﾭа SOX18 генﾭа. Показанﾭо је да регионﾭ 892 
бп узводнﾭо од АТГ кодонﾭа сﾭадржи регулаторнﾭе 
елеменﾭте нﾭеопходнﾭе за транﾭсﾭкрипцију и да овај 
регионﾭ сﾭадржи промотор SOX18 генﾭа.